TREA

88938201 - NABOTA

Follow

Information

  • Trademark
  • 88938201
  • Serial Number
    88938201
  • Registration Number
    6383994
  • Filing Date
    May 28, 2020
    4 years ago
  • Registration Date
    June 15, 2021
    3 years ago
  • Transaction Date
    June 15, 2021
    3 years ago
  • Status Date
    June 15, 2021
    3 years ago
  • Published for Opposition Date
    March 30, 2021
    3 years ago
  • Location Date
    June 15, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    FENNESSY, EDWARD JOHN
  • Attorney Name
    John M. Kim
    Law Office Assigned Location Code
    M50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
NABOTA
Case File Statements
  • GS0051: Botulinum toxin for medical use for use in the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction and pelvic pain; Pharmaceutical preparations, namely, acne medications, acne treatment preparations, adrenal hormone preparations, alcohol for topical use, allergy and allergy relief medications, analgesics, androgen preparations, anesthetics for surgical and non-surgical use, antacids, bactericides, antiarrhythmics, antibiotics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antivirals, anti-cancer preparations, anti-infectives, anti-inflammatories, antipyretics, antibacterial pharmaceuticals, calcium channel blockers, beta blockers, chemical compounds for drug delivery, eye drops, eye patches for medical purposes, hair growth stimulants, vaccines, vaccine adjuvants, vaccine stabilizers, diuretics, amino acids for medical purposes; Medicines for the treatment of gastrointestinal diseases; chemical preparations for pharmaceutical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; chemico-pharmaceutical preparations for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain. drugs for medical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; Medicines for human purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, and pelvic pain; pharmaceutical preparations for activating cellular function; Adjuvants for medical purposes; pharmaceutical preparations for central nerve treatment, namely, for the treatment of sequelae caused by damage to the central nerve in the brain; dermatological pharmaceutical products, namely, injectable botulinum toxin for refining wrinkles; pharmaceutical preparations for treating skin disorders; antibiotic preparations; pharmaceutical preparations for chemical disorder treatment, namely, for treatment of chemical imbalance in the brain
Case File Event Statements
  • 6/15/2021 - 3 years ago
    15 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/30/2021 - 3 years ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/30/2021 - 3 years ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/10/2021 - 3 years ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/22/2021 - 4 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/1/2021 - 4 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/1/2021 - 4 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/27/2021 - 4 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 10/15/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/28/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/28/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/28/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/28/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/17/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 6/1/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP